Your browser is no longer supported. Please, upgrade your browser.
Settings
WST West Pharmaceutical Services, Inc. daily Stock Chart
WST [NYSE]
West Pharmaceutical Services, Inc.
IndexS&P 500 P/E65.31 EPS (ttm)4.12 Insider Own0.20% Shs Outstand73.90M Perf Week-4.30%
Market Cap19.66B Forward P/E52.55 EPS next Y5.12 Insider Trans-15.50% Shs Float73.50M Perf Month-5.90%
Income311.70M PEG3.19 EPS next Q1.13 Inst Own94.40% Short Float0.85% Perf Quarter-1.72%
Sales2.04B P/S9.65 EPS this Y18.20% Inst Trans-0.60% Short Ratio1.42 Perf Half Y24.61%
Book/sh23.26 P/B11.57 EPS next Y12.84% ROA13.00% Target Price298.00 Perf Year81.72%
Cash/sh7.11 P/C37.85 EPS next 5Y20.50% ROE19.50% 52W Range124.53 - 305.00 Perf YTD79.07%
Dividend0.65 P/FCF85.99 EPS past 5Y12.90% ROI13.00% 52W High-11.74% Beta1.07
Dividend %0.24% Quick Ratio2.10 Sales past 5Y5.30% Gross Margin34.80% 52W Low116.17% ATR8.49
Employees8200 Current Ratio2.80 Sales Q/Q20.10% Oper. Margin18.10% RSI (14)40.29 Volatility3.03% 3.06%
OptionableYes Debt/Eq0.15 EPS Q/Q45.60% Profit Margin15.30% Rel Volume0.86 Prev Close267.71
ShortableYes LT Debt/Eq0.15 EarningsOct 22 BMO Payout15.20% Avg Volume442.15K Price269.20
Recom2.00 SMA20-4.84% SMA50-4.78% SMA20018.06% Volume378,341 Change0.56%
Nov-10-20Initiated KeyBanc Capital Markets Overweight $350
Oct-14-20Initiated Stephens Equal-Weight $300
Jul-21-20Upgrade BofA Securities Neutral → Buy $280
Apr-24-20Upgrade BofA/Merrill Underperform → Neutral $145 → $200
Dec-12-19Downgrade BofA/Merrill Neutral → Underperform
Jul-26-19Upgrade BofA/Merrill Underperform → Neutral
May-01-19Downgrade Jefferies Buy → Hold $122
Apr-23-19Initiated William Blair Outperform
Apr-25-18Downgrade BofA/Merrill Neutral → Underperform
Jan-24-18Initiated Goldman Neutral
Oct-17-17Downgrade BofA/Merrill Buy → Neutral
Oct-03-17Initiated Stephens Equal-Weight
Sep-15-17Upgrade Jefferies Hold → Buy
Oct-28-16Upgrade Wells Fargo Market Perform → Outperform
Sep-21-16Downgrade Wells Fargo Outperform → Market Perform
Mar-22-16Initiated Wells Fargo Outperform
May-14-10Reiterated UBS Neutral $41 → $44
Feb-23-10Initiated Jefferies & Co Buy $45
Dec-19-08Initiated UBS Neutral $41
Dec-19-08Initiated UBS Neutral
Nov-13-20 08:00AM  
Nov-12-20 10:11AM  
Nov-11-20 11:30AM  
08:38AM  
Nov-10-20 10:31AM  
08:25AM  
Nov-09-20 04:30PM  
10:17AM  
09:30AM  
Nov-06-20 11:05AM  
11:00AM  
10:14AM  
09:15AM  
08:46AM  
Nov-05-20 02:12PM  
10:34AM  
09:00AM  
08:55AM  
Nov-04-20 08:20AM  
Nov-03-20 10:05AM  
09:47AM  
09:17AM  
08:29AM  
08:19AM  
Nov-02-20 12:34PM  
11:13AM  
10:55AM  
10:45AM  
10:43AM  
Oct-30-20 11:49AM  
10:45AM  
Oct-29-20 11:40AM  
11:20AM  
09:33AM  
07:53AM  
Oct-28-20 12:06PM  
11:25AM  
06:00AM  
Oct-26-20 11:30AM  
08:00AM  
Oct-22-20 07:31PM  
05:00PM  
04:30PM  
07:30AM  
07:20AM  
06:00AM  
Oct-15-20 12:32PM  
Oct-14-20 10:01AM  
Oct-13-20 12:22PM  
Oct-12-20 11:40AM  
Oct-08-20 06:00AM  
Oct-06-20 11:26AM  
Oct-02-20 03:35PM  
Sep-30-20 03:19PM  
Sep-28-20 08:33PM  
Sep-18-20 03:42PM  
10:53AM  
08:58AM  
Sep-16-20 11:30AM  
Sep-10-20 04:41PM  
Sep-04-20 11:18AM  
Sep-02-20 05:37PM  
Aug-31-20 11:30AM  
10:25AM  
Aug-27-20 10:23AM  
07:24AM  
Aug-24-20 01:12PM  
Aug-18-20 12:45PM  
Aug-14-20 11:30AM  
Aug-06-20 08:44AM  
Aug-04-20 09:24AM  
Aug-03-20 11:05AM  
Jul-31-20 12:13PM  
Jul-30-20 06:43AM  
Jul-23-20 10:32PM  
10:51AM  
07:30AM  
07:15AM  
06:00AM  
Jul-22-20 12:10PM  
Jul-20-20 11:30AM  
Jul-17-20 10:34AM  
Jul-16-20 12:32PM  
Jul-15-20 11:40AM  
07:20AM  
06:00AM  
Jul-14-20 09:15AM  
Jul-13-20 11:55AM  
Jul-12-20 08:54PM  
Jul-09-20 06:00AM  
Jul-08-20 08:41AM  
Jul-06-20 10:07AM  
09:30AM  
09:28AM  
Jul-03-20 08:00AM  
Jul-02-20 10:16AM  
08:47AM  
Jul-01-20 09:33AM  
08:35AM  
Jun-30-20 09:38AM  
West Pharmaceutical Services, Inc. manufactures and sells containment and delivery systems for injectable drugs and healthcare products in the United States, Germany, Ireland, France, Other European countries, and internationally. The company operates through two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, and washing and sterilization processes and services to enhance the quality of packaging components. It also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices, as well as a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of components and devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. This segment serves pharmaceutical, diagnostic, and medical device companies. It distributes its products through its sales force and distribution network, as well as contract sales agents and regional distributors. The company was founded in 1923 and is headquartered in Exton, Pennsylvania.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
MILLER GEORGE LLOYDSr. VP, GC & Corp. Sec.Nov 06Option Exercise62.309,000560,70016,540Nov 09 06:36 PM
MILLER GEORGE LLOYDSr. VP, GC & Corp. Sec.Nov 06Sale296.679,0002,670,0417,540Nov 09 06:36 PM
MONTECALVO DAVID ASVP, Glob Ops and Supply ChainJul 29Option Exercise83.475,358447,2329,582Jul 30 06:22 PM
MONTECALVO DAVID ASVP, Glob Ops and Supply ChainJul 29Sale270.703,273886,0146,309Jul 30 06:22 PM
MONTECALVO DAVID ASVP, Glob Ops and Supply ChainJul 28Option Exercise74.3313,7921,025,16818,732Jul 30 06:22 PM
MONTECALVO DAVID ASVP, Glob Ops and Supply ChainJul 28Sale264.8214,5083,842,0474,224Jul 30 06:22 PM
Abraham SiljiChief Digital & Trans OfficerMay 11Option Exercise86.241,00086,2406,894May 12 02:11 PM
Abraham SiljiChief Digital & Trans OfficerMay 11Sale204.501,000204,5005,894May 12 02:11 PM
Abraham SiljiChief Digital & Trans OfficerMay 08Option Exercise86.241,00086,2406,894May 12 02:11 PM
Abraham SiljiChief Digital & Trans OfficerMay 08Sale200.001,000200,0005,894May 12 02:11 PM
MILLER GEORGE LLOYDSr. VP, GC & Corp. Sec.May 01Sale189.381,805341,8377,540May 05 05:13 PM
Abraham SiljiChief Digital & Trans OfficerApr 28Option Exercise86.2450043,1205,041Apr 30 12:10 PM
Abraham SiljiChief Digital & Trans OfficerApr 28Sale200.66500100,3284,541Apr 30 12:10 PM
Favorite Annette FSr. VP Human Resources OfficerApr 27Option Exercise55.0914,192781,83722,401Apr 29 04:48 PM
Favorite Annette FSr. VP Human Resources OfficerApr 27Sale196.9014,1922,794,4218,209Apr 29 04:48 PM
affiliate | advertise | contact | privacy | help
Do not sell my personal information

Quotes delayed 15 minutes for NASDAQ, and 20 minutes for NYSE and AMEX.
Copyright © 2007-2020 FINVIZ.com. All Rights Reserved.